SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-038203
Filing Date
2015-05-14
Accepted
2015-05-14 16:52:45
Documents
2
Period of Report
2015-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-11434_18k.htm 8-K 20550
2 EX-99.1 a15-11434_1ex99d1.htm EX-99.1 97099
  Complete submission text file 0001104659-15-038203.txt   118926
Mailing Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006
Business Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 15863682
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1